Schroder Investment Management Group’s IDEAYA Biosciences IDYA Stock Holding History

Schroder Investment Management Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.84M	Buy	187,017 +121,073	+184%	+$3.71M	﹤0.01%	732
2026 Q1	$2.07M	Sell	65,944 -105,334	-61%	-$3.53M	﹤0.01%	927
2025 Q4	$5.91M	Sell	171,278 -34,487	-17%	-$1.1M	﹤0.01%	727
2025 Q3	$5.59M	Sell	205,765 -15,187	-7%	-$367K	﹤0.01%	757
2025 Q2	$4.64M	Sell	220,952 -41,654	-16%	-$799K	﹤0.01%	778
2025 Q1	$4.48M	Buy	262,606 +33,290	+15%	+$709K	﹤0.01%	778
2024 Q4	$5.72M	Sell	229,316 -14,537	-6%	-$412K	0.01%	749
2024 Q3	$7.51M	Buy	243,853 +100,792	+70%	+$3.82M	0.01%	723
2024 Q2	$5.02M	Buy	143,061 +74,305	+108%	+$2.94M	0.01%	781
2024 Q1	$3.02M	Buy	+68,756	New	+$2.96M	﹤0.01%	867

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Schroder Investment Management Group's IDYA Position: Q2 2026 in Review

Schroder Investment Management Group increased its IDEAYA Biosciences (IDYA) stake by 184% in Q2 2026, buying an estimated $3.71M and bringing the position to 187,017 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Schroder Investment Management Group first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.51M in Q3 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Schroder Investment Management Group held 187,017 shares of IDEAYA Biosciences worth $6.84M as of Q2 2026.
Schroder Investment Management Group bought 121,073 IDEAYA Biosciences shares in Q2 2026, an estimated $3.71M.
IDEAYA Biosciences made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #732 holding.
Schroder Investment Management Group first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
Schroder Investment Management Group's IDEAYA Biosciences position peaked at $7.51M in Q3 2024.
285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.